AXT (AXTI) Q2 2026 earnings review
The Dam Breaks: AI Demand Drives a Massive Revenue and Margin Inflection
After multiple quarters of geopolitical bottlenecks and export permit delays, AXT's underlying AI demand story has violently materialized. Revenue accelerated 77% sequentially to $47.6 million, generating the highest quarterly Indium Phosphide (InP) sales in company history. More importantly, this volume surge triggered massive operational leverage: non-GAAP gross margin skyrocketed to 45.0% (up from 29.9% last quarter), pulling the company decisively out of the red with $11.9 million in non-GAAP net income. While the quarter is a masterclass in operating leverage, investors must weigh this explosive operational execution against significant recent share dilution and the ever-present specter of Chinese export controls.
🐂 Bull Case
The company proved that when volume flows, margins explode. Gross margins expanded to an exceptional 45.0%, validating management's claims that higher factory utilization and a richer InP product mix would drive profitability.
The long-awaited surge in Indium Phosphide demand for data center optical connectivity is no longer just a backlog metric—it is printing revenue. AXT is riding a wave of multi-year hyperscaler infrastructure investments.
🐻 Bear Case
Basic shares outstanding increased 40% year-over-year (from 43.7M to 61.2M). While the recent $632.5M capital raise shores up the balance sheet for capacity expansion, it structurally dilutes EPS for existing shareholders.
The PR omitted detailed updates on Chinese export permits. While Q2 shipments were clearly successful, the reliance on Beijing for permission to ship critical materials to US tech giants remains a permanent, unquantifiable risk.
⚖️ Verdict: 🟢
Highly Bullish. The sheer magnitude of the sequential margin and revenue expansion proves AXT's fundamental business model works at scale. If they can continue navigating export permits, the earnings power is immense.
Key Themes
Historic Gross Margin Expansion
Accelerating. Non-GAAP gross margin improved from 8.2% a year ago, to 29.9% in Q1, and now a stunning 45.0% in Q2. This 1,510 basis point sequential jump highlights the fixed-cost nature of AXT's substrate manufacturing. As high-margin Indium Phosphide (InP) becomes the dominant revenue stream and factory utilization spikes, the flow-through to the bottom line is dramatic.
AI Optical Connectivity Demand
Accelerating. Management explicitly cited 'strong customer demand for data center optical connectivity' as the catalyst for the quarter's record Indium Phosphide revenue. With hyperscalers driving 800G and 1.6T transceiver adoption, the requirement for AXT's low-EPD (Etch Pit Density) substrates is proving to be a structural, multi-year tailwind rather than a cyclical blip.
The Silent Export Permit Risk
Stable. While Q2's massive $47.6M revenue print clearly indicates that either domestic Chinese demand is soaring or export permits are being actively granted, the underlying risk remains. China's Ministry of Commerce controls the spigot for AXT's most critical AI products. Until direct-to-US export licenses are completely normalized, every quarter carries a geopolitical binary risk.
Heavy Shareholder Dilution
Decelerating EPS power per share. To fund its aggressive InP capacity expansion, AXT has materially diluted its equity base. Diluted shares used to compute EPS jumped to 63.5M in Q2, up from 43.7M a year ago. While the $11.1M GAAP net income is impressive, the per-share impact ($0.17) is dampened by the expanded share count.
Massive War Chest for Capacity Expansion
With the $632.5M capital raise (completed just after Q1 closed) now fully reflected, AXT's cash and short-term investments surged to $417.2M. This provides total financial security to execute their aggressive roadmap: doubling InP capacity by the end of 2026, and doubling it again by 2027 to capture the AI optical infrastructure market.
Other KPIs
A colossal increase from $120.3 million at the end of 2025. This reflects the injection of capital meant to fund the Tongmei subsidiary's multi-year capacity expansion. AXT is now incredibly well-capitalized to out-scale competitors.
GAAP operating expenses rose 34% YoY, but grew at a fraction of the 165% revenue growth rate. This tight cost control further enabled the quarter's spectacular operating leverage, turning a $6.7M operating loss last year into a $10.4M operating profit this quarter.
Up from $81.7 million at year-end. In a normal hardware company, this might signal a red flag. However, given AXT's stated strategy of building WIP (work-in-progress) to ship instantly once export permits are granted, and their aggressive capacity ramp, this inventory build is a necessary growth driver.
Key Questions
Geographic Mix & Export Permits
Of the record $47.6M in revenue, what percentage was shipped to domestic Chinese customers versus exported internationally? Are the export permit timelines for Indium Phosphide fully normalizing?
Structural Gross Margins
With non-GAAP gross margins hitting 45.0% this quarter, should investors view this as the new structural baseline, or were there one-time favorable product mix tailwinds that will normalize back into the 30s?
Long-Term Supply Agreements (LTSAs)
In Q1, management mentioned being in discussions with nearly all major customers regarding LTSAs. How many of these agreements have been formally signed, and what level of backlog visibility do they provide for 2027 and beyond?
6-Inch Wafer Commercialization
With the new capital deployed, what is the exact timeline for achieving volume production of 6-inch Indium Phosphide wafers, and what margin profile do they carry compared to current 4-inch output?